Therapeutic Areas
Psychiatry
- Addictions (alcohol, drugs, smoking, eating, opioid dependence)
- Adult and child ADHD
- Anxiety (SAD, GAD, OCD) and post traumatic stress disorder (PTSD)
- Bipolar disorder (both mania and depression)
- Child psychiatry
- Cognitive dysfunction
- Major depressive disorder (MDD), treatment resistant depression (TRD)
- Schizophrenia and schizoaffective disorders
Neurology
- Alzheimer’s
- Multiple Sclerosis
- Parkinson’s
- Post-stroke
- Traumatic brain injury (TBI)
- Tourette’s syndrome
Pain
- Acute and chronic pain (back, knee, shoulder)
- Fibromyalgia
- Migraine
- Neuropathic pain
- Opioid induced constipation (OIC)
- Osteoarthritis (OA)
- Pain modeling
- Post-surgical pain
Sleep
- Chronic Insomnia
- Excessive daytime sleepiness (EDS)
- Narcolepsy
- Obstructive sleep apnea (OSA)
- Polysomnography (PSG)
- Restless legs syndrome (RLS)
- Shift worker syndrome / jet lag
Dermatology
- Acne
- Atopic dermatitis
- Melanoma
- Psoriasis
- Rosacea
- Skin infections
- Devices studies involving lasers or liposuction
Ophthalmology
- Cataracts
- Conjunctivitis
- Dry eye syndrome
- Glaucoma
- Macular degeneration
General Medical
- Cardiology: atrial fibrillation, coronary syndromes, heart failure, hypertension, hypotension
- Endocrinology: diabetes, growth hormone deficiency, hyperthyroidism, hypothyroidism, osteoporosis
- Gastrointestinal: Crohn’s disease, irritable bowel syndrome (IBS-C & IBS-D), ulcerative colitis
- Immunology: allergies
- Infectious diseases: hepatitis B & C, HIV, influenza
- Metabolic disorders: metabolic syndrome, obesity
- Pulmonology/respiratory: asthma, chronic obstructive pulmonary disease (COPD)
- Renal/hepatic: non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), renal and hepatic impairment
- Women’s and men’s health: contraception, endometriosis, hot flashes, sexual dysfunction
Asian Bridging
- Japanese
- Chinese
- Taiwanese
- Other Asian populations
Human Abuse Liability
Healthy Volunteers
Including subpopulations of:
- Asians
- Elderly
- Post-menopausal females
- Tobacco Users
Phase I
- HNVs and patient populations including first in human (FIH)